Phosphorylcholine PC-mAb Effects in Subjects With Elevated Lipoprotein a
Clinical trial NCT03320265 · TERMINATED
Trial details
- NCT number
- NCT03320265
- Sponsor
- Athera Biotechnologies AB
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-11
- Primary completion
- 2018-03-19
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.